Intranasal insulin effect on cognitive and/or memory impairment: a systematic review and meta-analysis
Autor
Gómez-Guijarro, María Dolores
Cavero-Redondo, Iván
Saz-Lara, Alicia
Pascual-Morena, Carlos
Álvarez-Bueno, Celia
Martínez-García, Irene
Resumen
Background: Cognitive impairment, characterized by deficits in cognitive functions and loss of delayed and immediate recall, disproportionately affects individuals aged 65 years and older, particularly those with comorbid cardiovascular conditions such as hypertension and diabetes mellitus. Objective: This study aimed to investigate the potential association between intranasal insulin and cognitive and/or memory impairment, with a specific focus on delayed and immediate recall, considering the rising prevalence of cognitive disorders in the aging population. Methodology: Employing a rigorous systematic approach, we conducted a thorough search of MEDLINE, Scopus, the Cochrane database, and Web of Science from inception to November 23, 2022, identifying relevant randomized clinical trials. Our analyses encompassed three key aspects: (i) assessing the impact of intranasal insulin on cognitive impairment, (ii) evaluating its effect on delayed recall, and (iii) examining its influence on immediate recall. Results: Five studies meeting the inclusion criteria were included. The results underscored a statistically significant effect of intranasal insulin on delayed memory (effect size: 1.37; 95% CI: 0.65 to 2.09) and overall cognition (effect size: 0.58; 95% CI: 0.08 to 1.08). However, no statistically significant effect was observed for immediate memory (effect size: 0.48; 95% CI: -0.00 to 0.96). Conclusions: This study provides compelling evidence supporting the significance and efficacy of intranasal insulin in enhancing delayed recall and overall cognition. The observed effects hold promise for potential therapeutic interventions in addressing cognitive deficits associated with aging and comorbid conditions. The findings emphasize the need for further research to elucidate the underlying mechanisms and optimize the application of intranasal insulin in cognitive enhancement strategies. © The Author(s), under exclusive licence to Springer Nature B.V. 2024.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Efficacy of risdiplam in spinal muscular atrophy: A systematic review and meta-analysis (2024)
Pascual-Morena, Carlos; Martínez-Vizcaíno, Vicente; Cavero-Redondo, Iván; Martínez-García, Irene; Moreno-Herráiz, Nerea; Álvarez-Bueno, Celia; Saz-Lara, Alicia (American College of Clinical Pharmacy, 2024)This systematic review and meta-analysis aimed to assess the efficacy and safety of risdiplam on motor and respiratory function in spinal muscular atrophy (SMA). We systematically searched Medline, Scopus, Web of Science, ... -
Non-invasive skin autofluorescence as a screening method for diabetic retinopathy (2024)
Martínez-García, Irene; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Pascual-Morena, Carlos; Gómez-Guijarro, María Dolores; Saz-Lara, Alicia (John Wiley and Sons Ltd, 2024)Diabetic retinopathy (DR) is a public health problem and a common cause of blindness. It is diagnosed by fundus examination; however, this is a costly and time-consuming method. Non-invasive skin autofluorescence (SAF) may ... -
Article
Prevalence and genotypic associations of epilepsy in Prader-Willi Syndrome: A systematic review and meta-analysis (2024)
Pascual-Morena, Carlos; Martínez-Vizcaíno, Vicente; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Martínez-García, Irene; Rodríguez-Gutiérrez, Eva; Otero-Luis, Iris; del Saz-Lara, Andrea; Saz-Lara, Alicia (Academic Press Inc., 2024)Objective: To estimate the prevalence of epilepsy and febrile seizures and their association with genotype, i.e., 15q11-q13 deletions, uniparental chromosome 15 disomy (UPD) and other mutations, in the population with ...